ARCHIVES

ODAC Recommends Fludarabine Approval for Refractory CLL

This article is from The Cancer Letter archive.

Vol. 16 No. 36 | September 21, 1990

Download PDF Visit The Full Archive

Related Articles

$14.7 Million Earmark Of NCI funds Trigger Protest By Advocates, Scientists

October 24, 1996

Foundation Gives Duke $2M For Brain Tumor Research.

March 23, 2001

President Signs Interim Money Bill; NCI At $725 Million

July 4, 1975

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 12, 1974

NIH announces The Cancer Genome Atlas, new name for human cancer genome project.

December 16, 2005

Armstrong Foundation To Fund Studies In Testicular Cancer

April 17, 1998